Tracy M. Downs
Sherwood Forest Hospitals NHS Foundation Trust(GB)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Renal cell carcinoma treatment
Most-Cited Works
- → Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology(2020)623 cited
- → Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial(2020)417 cited
- → Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology(2017)278 cited
- → NCCN Guidelines Insights: Bladder Cancer, Version 5.2018(2018)217 cited
- → Racial/Ethnic and Gender Disparities in Renal Cell Carcinoma Incidence and Survival(2008)180 cited
- → Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study(2017)169 cited
- IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.